Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
第一作者:
Matthew J,Grigg
第一单位:
Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.;Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗疟药(Antimalarials);青蒿素类(Artemisinins);儿童(Child);儿童, 学龄前(Child, Preschool);氯喹(Chloroquine);抗药性(Drug Resistance);女(雌)性(Female);人类(Humans);婴儿(Infant);疟疾, 间日(Malaria, Vivax);男(雄)性(Male);甲氟喹(Mefloquine);中年人(Middle Aged);间日疟原虫(Plasmodium vivax);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1093/cid/ciw121
PMID
27107287
发布时间
2025-05-29
基金项目
- 浏览63
Clinical infectious diseases
1403-1411页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



